Skip to main content

Table 3 Number and percentage of significant DMPs in COST DMRs

From: Genome-wide methylation profiling of Beckwith-Wiedemann syndrome patients without molecular confirmation after routine diagnostics

Patient_ID Number of significant DMPs Number of significant DMPs in COST DMR % significant DMPs in COST DMPs
MLID BWS5 857 154 17.97
MLID BWS3 1903 226 11.88
MLID BWS1 1668 138 8.27
MLID BWS2 2779 161 5.79
MLID BWS4 1742 65 3.73
BWS7 1957 41 2.10
BWS22 1055 16 1.52
BWS25 9146 109 1.19
BWS5 1333 8 0.60
BWS24 13,898 77 0.55
BWS11 1102 6 0.54
BWS4 834 4 0.48
BWS23 476 2 0.42
BWS3 615 2 0.33
BWS1 1084 3 0.28
BWS16 441 1 0.23
BWS9 903 2 0.22
BWS12 474 1 0.21
BWS18 538 1 0.19
BWS17 545 1 0.18
BWS8 701 1 0.14
BWS10 1517 2 0.13
BWS13 479 0 0.00
BWS14 443 0 0.00
BWS15 551 0 0.00
BWS19 538 0 0.00
BWS20 419 0 0.00
BWS21 463 0 0.00
BWS2 735 0 0.00
BWS6 621 0 0.00